Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
IPO Year: 1995
Exchange: NASDAQ
Website: henryschein.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/14/2025 | $80.00 | Equal Weight | Wells Fargo |
| 1/6/2025 | $69.00 → $84.00 | Underperform → Buy | BofA Securities |
| 12/4/2024 | $75.00 | Neutral | Mizuho |
| 7/22/2024 | $81.00 → $92.00 | Neutral → Outperform | Robert W. Baird |
| 2/26/2024 | $78.00 | Market Perform | Leerink Partners |
| 12/12/2023 | $71.00 → $82.00 | Neutral → Overweight | JP Morgan |
| 11/10/2023 | $70.00 | Hold → Buy | Stifel |
| 8/8/2022 | $80.00 | Sell → Neutral | UBS |
| 7/21/2022 | $93.00 → $85.00 | Buy → Neutral | Goldman |
| 6/14/2022 | $103.00 → $88.00 | Outperform → Neutral | Robert W. Baird |
Recognition Honors Mr. Bergman's Leadership, Service, and Engagement within the Distribution Community Henry Schein, Inc. (NASDAQ:HSIC) announced today that Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, received the National Association of Wholesaler-Distributors (NAW) Dirk Van Dongen Lifetime Achievement Award. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250211556941/en/Left to right: Stanley Bergman, Kathy Mazzarella (Vice-Chair of NAW Board of Directors and Chairman, President, and CEO of Graybar), and Eric Hoplin (President and CEO, NAW). (Photo: Business Wire) The recognition pays tribute to in
The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi
Company Launches Video Featuring Athletic Trainers in Professional Sports Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (NASDAQ:HSIC), is paying tribute to women athletic trainers (ATs) during today's celebration of National Girls and Women in Sports Day 2025. Spotlighting four Women's National Basketball Association (WNBA) ATs, the Company's Athletics and Schools business today launched this video to showcase the critical role ATs play in the continuum of care and to recognize the increase of women ATs in sports. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250204520375/en/ Featuring Theresa Acosta (
KKR to become 12% common shareholder in Henry Schein Henry Schein and KKR to collaborate on range of value creation opportunities Two KKR representatives with deep sector experience to join the Henry Schein Board as independent directors Separately, Robert J. Hombach, who brings extensive financial and strategic experience in health care, has joined the Henry Schein Board as an independent director Announces preliminary unaudited fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19, and preliminary 2025 financial guidance for full-year non-GAAP EPS of low to mid single digit growth In addition, Henry Schein has increased its share repurchase progra
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter and full-year 2024 financial results before the stock market opens on Tuesday, February 25, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay
BOSTON and NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised Acentus in the acquisition of substantially all of its assets by Henry Schein, Inc. Acentus is a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Acentus Founders Brett Carroll, Todd Cianfrocca, Greg Duvall, and Julio Valdivia will join Henry Schein, bringing their expertise and experience in the product category and the healthcare industry. Provident's deal team was l
Henry Schein Home Solutions Business Expands with the Addition of Leading Supplier of Homecare Medical Products Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Henry Schein announced the agreement to acquire Acentus on November 20, 2024. Headquartered in Tampa, Florida, Acentus reports annual revenue of approximately $35 million. Henry Schein expects the transaction to be neutral to 2025 non-GAAP earnings per
Dental and Medical Professionals Who May Experience Operational, Logistical, or Financial Issues Are Encouraged to Call 800-999-9729 Henry Schein, Inc. (NASDAQ:HSIC) reminds its customers throughout California that the Henry Schein Customer Emergency Support Hotline is open for dental and medical professionals who may experience operational, logistical, or financial issues as a result of damage caused by the ongoing fires. The toll-free number for all Henry Schein customers is 800-999-9729. The hotline is open 24/7, with real-time assistance available from Team Schein Members from 8 a.m. to 8 p.m. Eastern Time. "We are deeply saddened by the immense loss caused by the fires in Califor
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at J.P. Morgan's Healthcare Investor Conference on Tuesday, January 14, 2025, at 3:00 p.m. PST / 6:00 p.m. EST, at The Westin St. Francis Hotel in San Francisco. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. About Henry Schein, Inc. Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. Wit
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in December: Piper Sandler's Healthcare Conference at Lotte New York Palace Hotel, New York, on December 4, 2024, at 11:00 a.m. Eastern time. Evercore ISI HealthCONx Conference at Loews Coral Gables Hotel, Coral Gables, Florida, on December 5, 2024, at 9:10 a.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website following the presentations. Abo
Wells Fargo initiated coverage of Henry Schein with a rating of Equal Weight and set a new price target of $80.00
BofA Securities upgraded Henry Schein from Underperform to Buy and set a new price target of $84.00 from $69.00 previously
Mizuho initiated coverage of Henry Schein with a rating of Neutral and set a new price target of $75.00
Robert W. Baird upgraded Henry Schein from Neutral to Outperform and set a new price target of $92.00 from $81.00 previously
Leerink Partners initiated coverage of Henry Schein with a rating of Market Perform and set a new price target of $78.00
JP Morgan upgraded Henry Schein from Neutral to Overweight and set a new price target of $82.00 from $71.00 previously
Stifel upgraded Henry Schein from Hold to Buy and set a new price target of $70.00
UBS upgraded Henry Schein from Sell to Neutral and set a new price target of $80.00
Goldman downgraded Henry Schein from Buy to Neutral and set a new price target of $85.00 from $93.00 previously
Robert W. Baird downgraded Henry Schein from Outperform to Neutral and set a new price target of $88.00 from $103.00 previously
KKR to become 12% common shareholder in Henry Schein Henry Schein and KKR to collaborate on range of value creation opportunities Two KKR representatives with deep sector experience to join the Henry Schein Board as independent directors Separately, Robert J. Hombach, who brings extensive financial and strategic experience in health care, has joined the Henry Schein Board as an independent director Announces preliminary unaudited fourth-quarter 2024 GAAP diluted EPS of $0.74 and non-GAAP diluted EPS of $1.19, and preliminary 2025 financial guidance for full-year non-GAAP EPS of low to mid single digit growth In addition, Henry Schein has increased its share repurchase progra
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its fourth quarter and full-year 2024 financial results before the stock market opens on Tuesday, February 25, 2025, and will provide a live webcast of its earnings conference call on the same day beginning at 8:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay
Henry Schein Home Solutions Business Expands with the Addition of Leading Supplier of Homecare Medical Products Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the acquisition of substantially all of the assets of Acentus, a national medical supplier specializing in the delivery of Continuous Glucose Monitors (CGMs). Henry Schein announced the agreement to acquire Acentus on November 20, 2024. Headquartered in Tampa, Florida, Acentus reports annual revenue of approximately $35 million. Henry Schein expects the transaction to be neutral to 2025 non-GAAP earnings per
Third-quarter 2024 GAAP diluted EPS of $0.78 and non-GAAP diluted EPS of $1.22 Operating cash flow of $151 million for the third quarter of 2024; year-to-date operating cash flow of $644 million, up $112 million compared with year-to-date 2023 Increases 2024 full-year non-GAAP EPS guidance to $4.74 to $4.82 from $4.70 to $4.82 Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the third quarter ended September 28, 2024. "Our businesses performed well during the third quarter, driven by the continued successful implementation of our BOLD+1 Strategic Plan that is
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its third quarter 2024 financial results before the stock market opens on Tuesday, November 5, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be availabl
Highlights: Second-quarter 2024 GAAP diluted EPS of $0.80, and non-GAAP diluted EPS of $1.23 Operating cash flow of $296 million for the second quarter of 2024, year-to-date operating cash flow of $493 million up $192 million compared with year-to-date 2023 2024 full-year non-GAAP EPS guidance updated to $4.70 to $4.82 New restructuring plan targeting $75 million to $100 million in annual run-rate savings Share repurchase authorization increased by $500 million Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended June 29, 2024.
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its second quarter 2024 financial results before the stock market opens on Tuesday, August 6, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be availab
First-quarter 2024 sales growth of 3.7%, GAAP diluted EPS of $0.72 and non-GAAP diluted EPS of $1.10 Tightens total sales growth guidance range to 8% to 10%, reflecting continued recovery from last year's cyber incident and a strong pipeline of new specialty products and software innovation Affirms 2024 non-GAAP diluted EPS guidance of $5.00 to $5.16 and 2024 Adjusted EBITDA growth of more than 15% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the first quarter ended March 30, 2024. "Our first-quarter financial results reflect solid earnings driven by
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that it will release its first quarter 2024 financial results before the stock market opens on Tuesday, May 7, 2024, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Ronald N. South, Senior Vice President and Chief Financial Officer. Investors can access the call by visiting https://investor.henryschein.com/webcasts. A replay will be available o
Company Expands into High-Growth Extremities Market with Strategic Acquisition Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced it has completed the acquisition of TriMed, Inc., a global developer of solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist). Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023. The addition of TriMed will strengthen Henry Schein's deep and longstanding relationship with existing Integrated Delivery Networks (IDNs) and Ambulatory Surgery C
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
S-8 - HENRY SCHEIN INC (0001000228) (Filer)
S-8 - HENRY SCHEIN INC (0001000228) (Filer)
10-Q - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
10-Q - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
11-K - HENRY SCHEIN INC (0001000228) (Filer)
SD - HENRY SCHEIN INC (0001000228) (Filer)
8-K - HENRY SCHEIN INC (0001000228) (Filer)
3 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4/A - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
4 - HENRY SCHEIN INC (0001000228) (Issuer)
The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025 The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S. This press release features multimedia. Vi
Joining Henry Schein's EMC are Steve Boggan and Bianka Wilson, Co-CEOs of the Global Oral Reconstruction Group, and Tom Popeck, CEO of the Healthcare Specialties Group Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today announced that it has appointed three new members to the Company's Executive Management Committee (EMC) – Steve Boggan and Bianka Wilson, who were recently named Co-CEOs of the Company's Global Oral Reconstruction Group (GORG), and Tom Popeck, CEO of the Company's Healthcare Specialties Group (HSG). This press release features multimedia. View the full release here: https://www.busi
Applications for the Second Annual 2024 S.M.I.L.E. Healthcare Pathway Program are now being accepted Henry Schein, Inc. (NASDAQ:HSIC), National Dental Association (NDA), and Schattner Foundation are pleased to partner and present the S.M.I.L.E. (Student Mentoring with Immersive Learning and Enrichment) Healthcare Pathway Program. This innovative public-private partnership is designed to mentor and support aspiring healthcare professionals and enhance inclusivity within the dental field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240220083937/en/ Applications are now being accepted for the 2024 program taking place July 7 t
WASHINGTON, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The American Dental Association Foundation's Give Kids A Smile® (GKAS) program, one of the largest national initiatives focused on children and dental care, is kicking off at Howard University College of Dentistry on Thursday, Feb. 1 and Friday, Feb. 2, 2024. The American Dental Association (ADA) launched Give Kids A Smile 22 years ago as a way for dentists across the country to join with others in the community to provide free dental services to underserved children while also highlighting for policy makers the ongoing challenges that underserved families face in finding and affording dental care. The national Give Kids A Smile kick-of
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that its Board of Directors has appointed Carole T. Faig as an independent director to serve until the 2024 Annual Meeting of Stockholders in May, when she is expected to stand for re-election to the Board by a vote of the Company's stockholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231218305776/en/Carole T. Faig (Photo: Business Wire) Ms. Faig brings to Henry Schein extensive expertise in finance, audit, and public accounting and particular experience in the health c
Clark Named to New Position as Chief Global Customer Experience Officer Benowitz Named to New Position as Chief Global Digital Transformation Officer Appointments Advance Implementation of 2022-2024 BOLD+1 Strategic Plan Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today the appointment of two executives – Trinh Clark and Leigh Benowitz – to the Company's Executive Management Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220801005699/en/Pictured left to right: Trinh Clark, Senior Vice President and Chief Globa
Nancy Lanni, Experienced Health Care Leader, Named Vice President and General Manager, Strategic Account Management Team Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today the appointment of Dirk Benson to the position of Vice President and Chief Commercial Officer of the Company's North America Distribution Group (NADG). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220516006085/en/Dirk Benson, Vice President and Chief Commercial Officer, North America Distribution Group, Henry Schein. (Photo: Business Wire) In this new posit
Gerald A. Benjamin will retire as Chief Administrative Officer Michael S. Ettinger will be promoted to Chief Operating Officer Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Gerald A. Benjamin plans to retire as Executive Vice President and Chief Administrative Officer, effective July 1, 2022, after 34 years with the Company. Mr. Benjamin, who will also retire from Henry Schein's Board of Directors at the end of his current term in May, will remain an adviser to the Company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/
CFO Steven Paladino will retire on April 29, 2022, to be succeeded by Ronald N. South, Henry Schein's Vice President, Corporate Finance and Chief Accounting Officer Mr. Paladino to remain a member of Henry Schein's Board of Directors and become an adviser to the Company following retirement Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Steven Paladino plans to retire as Executive Vice President and Chief Financial Officer, effective April 29, 2022, after 35 years with the Company. Ronald N. South, Henry Schein's Vice President, Corporate Finance since 2008 and Chief Accoun
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that it has appointed Graham Stanley as Vice President of Investor Relations and Strategic Financial Project Officer. In this role, Graham will be responsible for driving Henry Schein's strategic communications with institutional investors and the securities analyst community as well as providing executive oversight from a financial perspective for several strategic initiatives. "Graham brings to this new role deep experience in finance management and leadership," said Steven Paladino, Executive Vice President and Chief Financial Officer.